Search - tctmd.com

Displaying 701 - 719 of 719

Sort: Relevancy | Date

News Daily News

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Yael L. Maxwell

January 03, 2018

News Daily News

Youth Use of Cigarette Alternatives May Raise Risk of Trying the Real Thing

Caitlin E. Cox

January 03, 2018

News Daily News

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

Michael O'Riordan

January 02, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Daily News

The Biggest News of 2017: TCTMD’s Top 10

Shelley Wood

January 01, 2018

Presentation Controversies and Advances 2017

Example of Sex Differences of Clinical Importance

Presenter: Viviany Taqueti

November 17, 2017

Presentation Controversies and Advances 2017

Does IMPROVE-IT and FOURIER. Confirm or Refute the LDL Hypothesis?

Presenter: Sanjay Kaul

November 16, 2017

Presentation Controversies and Advances 2017

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Presenter: Sanjay Kaul

November 16, 2017

Presentation Controversies and Advances 2017

Sex Considerations in the FDA Drug Review Pipeline and Drug Trial Snapshots

Presenter: Marjorie R. Jenkins

November 16, 2017

Presentation Controversies and Advances 2017

Rise, Fall And Resurrection of Renal Denervation

Presenter: Michael A. Weber

November 16, 2017

CME

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

BIO

Luai Tabaza, MD

BIO

Ajar Kochar, MD, MHS

News Industry News

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

CME

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Case

Rotablating the Un-dialatable Lesions

March 31, 2018

CME

Advertisement

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Youth Use of Cigarette Alternatives May Raise Risk of Trying the Real Thing

Ten Principles for Successful Treatment of HF With Reduced EF: New ACC Decision Pathway

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

The Biggest News of 2017: TCTMD’s Top 10

Example of Sex Differences of Clinical Importance

Does IMPROVE-IT and FOURIER. Confirm or Refute the LDL Hypothesis?

Targeting Inflammation in Atherosclerosis: Has CANTOS Nailed It?

Sex Considerations in the FDA Drug Review Pipeline and Drug Trial Snapshots

Rise, Fall And Resurrection of Renal Denervation

Everyday Antiplatelet Decisions: Making the Right Choices

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Luai Tabaza, MD

Ajar Kochar, MD, MHS

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Rotablating the Un-dialatable Lesions

TAVR: The Heart Team Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content